Aug 2026· Frontiers in Immunology· Vol 17· 0 citations· 38 references
Medicine
TL;DR
A single-cell atlas of metabolic states in healthy and transplanted human kidney samples offers novel insights into the heterogeneous nature of rejection and provides valuable guidance for the development of targeted therapies.
Abstract
Introduction Chronic rejection remains a major barrier to long-term survival after renal transplantation. However, our understanding of the transcriptional programs and metabolic alterations that shape the functions of human kidney cell populations during rejection is still limited. Objectives To generate a comprehensive, cell type–specific transcriptomic map of metabolic states in healthy and transplanted human kidney samples. Methods We performed single-cell RNA sequencing on 33 kidney samples, constructing an atlas comprising 82,661 cells. Results Analysis of average metabolic pathway activity across cell subpopulations revealed distinct metabolic profiles. These differences provided insights into both unique abnormalities and shared features underlying various rejection states. We identified downregulation of mitochondrial programs in multiple non-proximal tubular cell populations compared with their counterparts in healthy kidneys. In contrast, both proximal tubular (PT) cells and T cells exhibited relatively elevated oxidative phosphorylation-related transcriptional scores, though the mechanisms driving this shift were specific to cell type and rejection status. Additionally, rejection-associated macrophages demonstrated altered amino acid metabolism, accompanied by enhanced IL-1 signaling. Conclusion This single-cell atlas, together with a metabolically based stratification of chronic kidney transplant rejection, offers novel insights into the heterogeneous nature of rejection and provides valuable guidance for the development of targeted therapies.
Using spatial transcriptomics on longitudinal human cardiac biopsies, Amancherla, Oill and colleagues reveal marked cellular and molecular heterogeneity in transplanted hearts undergoing rejection, identify gene expression profiles linked to therapy response and outcomes, and show that acute rejection signatures are as...
Kaushik V. Amancherla, A. M. Taravella Oill, Xavier Bledsoe et al.· Nature Cardiovascular Resear...· 1 citation
The molecular profile of donor kidneys is extensively remodeled during NMP, creating an ex vivo state that diverges considerably from in vivo physiology, challenging the use of in vivo biomarkers for ex vivo assessment.
V. Lantinga, Y. Zuo, C. Jaynes et al.· Kidney International· 0 citations
This experimental-computational framework offers a generalizable strategy for characterizing partially reprogrammed states and guiding optimization of reprogramming protocols.
Jillian Cwycyshyn, Cooper M. Stansbury, S. Golts et al.· iScience· 0 citations
An integrative single cell framework is developed to reconstruct the mouse DNT cell landscape across tissues using multiple public single cell RNA sequencing datasets and provides a generalizable integrative strategy for reconstructing and characterizing rare immune cell populations that are insufficiently represented...
Jun Zhao, Jiang Zhu, Jian Zhang· International Journal of Mol...· 0 citations
Integrated multi-omic profiling of human tumor-infiltrating T cells reveals cell-intrinsic regulators of T cell dysfunction that are missed by transcriptomic analyses alone, highlighting an additional layer of regulatory control.
Kaspar Bresser, Zan Hozjan, N. Servaas et al.· bioRxiv· 0 citations
Summary Recent findings suggest that the orphan nuclear receptor 4A (NR4A) can regulate cellular energetics and epithelial defenses, contributing to a resilient, disease-resistant phenotype. To further examine the effects of NR4A on intestinal epithelial, stromal, and immune cell homeostasis, we performed single-cell t...
Selim Romero, Shreyan Gupta, Michael L. Salinas et al.· iScience· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.